O2‐04‐02: Astrocytes preferentially degrade apoE4: Impact on Aβ levels and neuronal plasticity in apoE targeted replacement mice
David Riddell(Eli Lilly (United States)), Peter H. Reinhart(University of Massachusetts Amherst), Lucy Y. Xu(Princeton University), Menelas N. Pangalos(AstraZeneca (United Kingdom)), Jia Xu(Princeton University), Steven J. Jacobsen(Mayo Clinic), A. Parratt(Princeton University), Wendy Stewart(Princeton University), Z. Li(Princeton University), Hua Zhou(Dalian Medical University), Erik Wagner(Princeton University), Julius J. Jefferson(Princeton University), Peter J. Atkinson(Princeton University), Kevin Atchison(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yolanda Kirksey(Princeton University), Helen K. Warwick(Princeton University), Margaret M. Zaleska, Suzan Aschmies(Princeton University), Yun Hu(Princeton University)
Cited by 0
Related Papers
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Proteogenomic Characterization of Endometrial Carcinoma
|Cell|2020|534
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
|Nature Medicine|2020|445
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
|Journal of Neuroscience|2008|351